Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization

European Journal of Immunology

Volumn 41, Issue 4, 2011, Pages 916-925

  Singh, Satwinder Kaur ^a   Streng Ouwehand, Ingeborg ^a   Litjens, Manja ^a   Kalay, Hakan ^a   Burgdorf, Sven ^b   Saeland, Eirikur ^a   Kurts, Christian ^b   Unger, Wendy W ^a   van Kooyk, Yvette ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Antigen presentation; Cross presentation; DC targeting; Glycans; MR

Indexed keywords

GAMMA INTERFERON; GLYCAN; GLYCOCONJUGATE; MANNOSE RECEPTOR; N ACETYLGLUCOSAMINE; OVALBUMIN; TOLL LIKE RECEPTOR; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL POLARITY; CELL PROLIFERATION; CELLS, CULTURED; CROSS-PRIMING; ENDOSOMES; GLYCOCONJUGATES; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; OLIGOSACCHARIDES; RECEPTORS, CELL SURFACE; TH1 CELLS; TOLL-LIKE RECEPTORS; TRISACCHARIDES;

EID: 79953062174     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040762     Document Type: Article

References (35)

1. Carbone, F. R. and Bevan, M. J., Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 1990. 171: 377-387.
2. Zou, W., Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 2005. 5: 263-274.
3. Zou, W., Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006. 6: 295-307.
4. Mahnke, K., Schonfeld, K., Fondel, S., Ring, S., Karakhanova, S., Wiedemeyer, K., Bedke, T. et al., Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro. Int. J. Cancer 2007. 120: 2723-2733.
5. Chen, A., Liu, S., Park, D., Kang, Y. and Zheng, G., Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer. Cancer Res. 2007. 67: 1291-1298.
6. Boissonnas, A., Scholer-Dahirel, A., Simon-Blancal, V., Pace, L., Valet, F., Kissenpfennig, A., Sparwasser, T. et al., Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity 2010. 32: 266-278.
7. Taylor, M. E., Bezouska, K. and Drickamer, K., Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor. J. Biol. Chem. 1992. 267: 1719-1726.
8. Taylor, P. R., Gordon, S. and Martinez-Pomares, L., The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol. 2005. 26: 104-110.
9. Leteux, C., Chai, W., Loveless, R. W., Yuen, C. T., Uhlin-Hansen, L., Combarnous, Y., Jankovic, M. et al., The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood group Lewis(a) and Lewis(x) types in addition to the sulfated N-glycans of lutropin. J. Exp. Med. 2000. 191: 1117-1126.
10. Liu, Y., Chirino, A. J., Misulovin, Z., Leteux, C., Feizi, T., Nussenzweig, M. C. and Bjorkman, P. J., Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand. J. Exp. Med. 2000. 191: 1105-1116.
11. Engering, A. J., Cella, M., Fluitsma, D. M., Hoefsmit, E. C., Lanzavecchia, A. and Pieters, J., Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv. Exp. Med. Biol. 1997. 417: 183-187.
12. Tan, M. C., Mommaas, A. M., Drijfhout, J. W., Jordens, R., Onderwater, J. J., Verwoerd, D., Mulder, A. A. et al., Mannose receptor mediated uptake of antigens strongly enhances HLA-class II restricted antigen presentation by cultured dendritic cells. Adv. Exp. Med. Biol. 1997. 417: 171-174.
13. Ramakrishna, V., Treml, J. F., Vitale, L., Connolly, J. E., O'Neill, T., Smith, P. A., Jones, C. L. et al., Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. J. Immunol. 2004. 172: 2845-2852.
14. Burgdorf, S., Kautz, A., Bohnert, V., Knolle, P. A. and Kurts, C., Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007. 316: 612-616.
15. Burgdorf, S., Scholz, C., Kautz, A., Tampe, R. and Kurts, C., Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat. Immunol. 2008. 9: 558-566.
16. Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Middel, J., Cornelissen, I. L. M. H. et al., DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000. 100: 587-597.
17. Engering, A., Geijtenbeek, T. B., Van Vliet, S. J., Wijers, M., van, L. E., Demaurex, N., Lanzavecchia, A. et al., The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 2002. 168: 2118-2126.
18. Chatterjee, D., Roberts, A. D., Lowell, K., Brennan, P. J. and Orme, I. M., Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect. Immun. 1992. 60: 1249-1253.
19. van, d. V., Marijnissen, R. J., Kullberg, B. J., Koenen, H. J., Cheng, S. C., Joosten, I., van den Berg, W. B. et al., The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009. 5: 329-340.
20. McKenzie, E. J., Taylor, P. R., Stillion, R. J., Lucas, A. D., Harris, J., Gordon, S. and Martinez-Pomares, L., Mannose receptor expression and function define a new population of murine dendritic cells. J. Immunol. 2007. 178: 4975-4983.
21. Burgdorf, S., Lukacs-Kornek, V. and Kurts, C., The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J. Immunol. 2006. 176: 6770-6776.
22. Sun, J. C. and Bevan, M. J., Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003. 300: 339-342.
23. Wong, S. B., Bos, R. and Sherman, L. A., Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells. J. Immunol. 2008. 180: 3122-3131.
24. Taylor, M. E. and Drickamer, K., Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor. J. Biol. Chem. 1993. 268: 399-404.
25. Fiete, D. J., Beranek, M. C. and Baenziger, J. U., A cysteine-rich domain of the "mannose" receptor mediates GalNAc-4-SO4 binding. Proc. Natl. Acad. Sci. USA 1998. 95: 2089-2093.
26. Galustian, C., Park, C. G., Chai, W., Kiso, M., Bruening, S. A., Kang, Y., Steinman, R. M. and Feizi, T., High and low affinity carbohydrate ligands revealed for murine SIGNR1 by carbohydrate array and cell binding approaches, and differing specificities for SIGNR3 and langerin. Int. Immunol. 2004. 16: 853-866.
27. Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., Miller, J. F. and Kosaka, H., Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 1996. 184: 923-930.
28. Kurts, C., Cannarile, M., Klebba, I. and Brocker, T., Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 2001. 166: 1439-1442.
29. Geijtenbeek, T. B. and Gringhuis, S. I., Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 2009. 9: 465-479.
30. He, L. Z., Crocker, A., Lee, J., Mendoza-Ramirez, J., Wang, X. T., Vitale, L. A., O'Neill, T. et al., Antigenic targeting of the human mannose receptor induces tumor immunity. J. Immunol. 2007. 178: 6259-6267.
31. Apostolopoulos, V., Barnes, N., Pietersz, G. A. and McKenzie, I. F., Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. Vaccine 2000. 18: 3174-3184.
32. Apostolopoulos, V., Pietersz, G. A., Gordon, S., Martinez-Pomares, L. and McKenzie, I. F., Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway. Eur. J. Immunol. 2000. 30: 1714-1723.
33. Karanikas, V., Hwang, L. A., Pearson, J., Ong, C. S., Apostolopoulos, V., Vaughan, H., Xing, P. X. et al., Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J. Clin. Invest. 1997. 100: 2783-2792.
34. Apostolopoulos, V., Pietersz, G. A., Tsibanis, A., Tsikkinis, A., Drakaki, H., Loveland, B. E., Piddlesden, S. J. et al., Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]. Breast Cancer Res. 2006. 8: R27.
35. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rossner, S., Koch, F., Romani, N. and Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999. 223: 77-92.